232 related articles for article (PubMed ID: 33306003)
1. Long-Term Changes in the Treatment Pattern of Botulinum Toxin A Injections for Postfacial Paralysis Synkinesis Following Modified Selective Neurectomy.
Hjelm N; Crippen M; Azizzadeh B
Facial Plast Surg Aesthet Med; 2021; 23(3):234-235. PubMed ID: 33306003
[No Abstract] [Full Text] [Related]
2. Therapeutic strategies in post-facial paralysis synkinesis in adult patients.
Terzis JK; Karypidis D
Plast Reconstr Surg; 2012 Jun; 129(6):925e-939e. PubMed ID: 22634691
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients.
Terzis JK; Karypidis D
J Plast Reconstr Aesthet Surg; 2012 Aug; 65(8):1009-18. PubMed ID: 22483723
[TBL] [Abstract][Full Text] [Related]
4. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
[TBL] [Abstract][Full Text] [Related]
5. Modified Selective Neurectomy for the Treatment of Post-Facial Paralysis Synkinesis.
Azizzadeh B; Irvine LE; Diels J; Slattery WH; Massry GG; Larian B; Riedler KL; Peng GL
Plast Reconstr Surg; 2019 May; 143(5):1483-1496. PubMed ID: 30807497
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of selective neurectomy for refractory periocular synkinesis.
van Veen MM; Dusseldorp JR; Hadlock TA
Laryngoscope; 2018 Oct; 128(10):2291-2295. PubMed ID: 29668050
[TBL] [Abstract][Full Text] [Related]
7. Quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type A.
Cecini M; Pavese C; Comelli M; Carlisi E; Sala V; Bejor M; Toffola ED
Plast Reconstr Surg; 2013 Nov; 132(5):1255-1264. PubMed ID: 24165606
[TBL] [Abstract][Full Text] [Related]
8. Epidemiologic Overview of Synkinesis in 353 Patients with Longstanding Facial Paralysis under Treatment with Botulinum Toxin for 11 Years.
Salles AG; da Costa EF; Ferreira MC; do Nascimento Remigio AF; Moraes LB; Gemperli R
Plast Reconstr Surg; 2015 Dec; 136(6):1289-1298. PubMed ID: 26595022
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis.
Choi KH; Rho SH; Lee JM; Jeon JH; Park SY; Kim J
J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1058-63. PubMed ID: 23683725
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
[TBL] [Abstract][Full Text] [Related]
12. Surgical Management of Postparalysis Facial Palsy and Synkinesis.
Azizzadeh B; Frisenda JL
Otolaryngol Clin North Am; 2018 Dec; 51(6):1169-1178. PubMed ID: 30170699
[TBL] [Abstract][Full Text] [Related]
13. Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis.
Shinn JR; Nwabueze NN; Du L; Patel PN; Motamedi KK; Norton C; Ries WR; Stephan SJ
JAMA Facial Plast Surg; 2019 May; 21(3):244-251. PubMed ID: 30703206
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapy with botulinum toxin in facial synkinesis: Retrospective data analysis of data from 1998 to 2018.
Alipour S; Pick C; Jansen S; Rink S; Klußmann JP; Grosheva M
Clin Otolaryngol; 2021 Jul; 46(4):758-766. PubMed ID: 33534183
[TBL] [Abstract][Full Text] [Related]
15. An objective assessment of botulinum toxin type A injection in the treatment of post-facial palsy synkinesis and hyperkinesis using the synkinesis assessment questionnaire.
Neville C; Venables V; Aslet M; Nduka C; Kannan R
J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1624-1628. PubMed ID: 28688864
[TBL] [Abstract][Full Text] [Related]
16. Platysma synkinesis in facial palsy and botulinum toxin type A.
Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
[TBL] [Abstract][Full Text] [Related]
17. Congenital Unilateral Lower Lip Palsy With Concurrent Hypoplasia of the Platysma Muscle.
Baltu Y; Baltu D
Dermatol Surg; 2018 Nov; 44(11):1480-1481. PubMed ID: 29406489
[No Abstract] [Full Text] [Related]
18. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.
McElhinny ER; Reich I; Burt B; Mancini R; Wladis EJ; Durairaj VD; Shinder R
Ophthalmic Plast Reconstr Surg; 2013; 29(3):175-8. PubMed ID: 23467287
[TBL] [Abstract][Full Text] [Related]
19. Contemporary Review and Case Report of Botulinum Resistance in Facial Synkinesis.
Shinn JR; Nwabueze NN; Patel P; Norton C; Ries WR; Stephan SJ
Laryngoscope; 2019 Oct; 129(10):2269-2273. PubMed ID: 30592301
[TBL] [Abstract][Full Text] [Related]
20. Modified Selective Neurectomy: A New Paradigm in the Management of Facial Palsy with Synkinesis.
Azizzadeh B; Hjelm N
Facial Plast Surg Clin North Am; 2021 Aug; 29(3):453-457. PubMed ID: 34217449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
